Wellington Biomedical Innovation Master Investors (Cayman) I L.P. is > 10% Shareholder of Nuvalent, Inc.. Currently has a direct ownership of 897,671 shares of NUVL, which is worth approximately $75.3 Million. The most recent transaction as insider was on Aug 02, 2021, when has been sold 897,671 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 898K
0% 3M change
0% 12M change
Total Value Held $75.3 Million

Wellington Biomedical Innovation Master Investors (Cayman) I L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 02 2021
BUY
Conversion of derivative security
-
897,671 Added 50.0%
897,671 Class A Common Stock

Also insider at

VERV
Verve Therapeutics, Inc. Healthcare
EWTX
Edgewise Therapeutics, Inc. Healthcare
OLMA
Olema Pharmaceuticals, Inc. Healthcare
ALGS
Aligos Therapeutics, Inc. Healthcare
RTVA
Artiva Biotherapeutics, Inc.
ACRV
Acrivon Therapeutics, Inc.
BOLD
Boundless Bio, Inc.
ZBIO
Zenas BioPharma, Inc.
WBI

Wellington Biomedical Innovation Master Investors (Cayman) I L.P.

> 10% Shareholder
Boston, MA

Track Institutional and Insider Activities on NUVL

Follow Nuvalent, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVL shares.

Notify only if

Insider Trading

Get notified when an Nuvalent, Inc. insider buys or sells NUVL shares.

Notify only if

News

Receive news related to Nuvalent, Inc.

Track Activities on NUVL